Universal Beteiligungs und Servicegesellschaft mbH Makes New $645,000 Investment in National Health Investors, Inc. (NYSE:NHI)

Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in National Health Investors, Inc. (NYSE:NHIFree Report) in the 1st quarter, according to its most recent disclosure with the SEC. The fund acquired 8,726 shares of the real estate investment trust’s stock, valued at approximately $645,000.

A number of other institutional investors have also recently modified their holdings of the stock. Allianz Asset Management GmbH raised its stake in National Health Investors by 104.0% in the first quarter. Allianz Asset Management GmbH now owns 56,928 shares of the real estate investment trust’s stock valued at $4,205,000 after purchasing an additional 29,016 shares in the last quarter. Private Advisor Group LLC increased its holdings in National Health Investors by 159.5% in the 1st quarter. Private Advisor Group LLC now owns 15,206 shares of the real estate investment trust’s stock valued at $1,123,000 after buying an additional 9,346 shares during the period. Bailard Inc. bought a new position in National Health Investors in the 1st quarter valued at about $729,000. Xponance Inc. raised its position in shares of National Health Investors by 11.2% in the 1st quarter. Xponance Inc. now owns 3,334 shares of the real estate investment trust’s stock valued at $246,000 after buying an additional 337 shares in the last quarter. Finally, DekaBank Deutsche Girozentrale lifted its holdings in shares of National Health Investors by 4.3% during the 1st quarter. DekaBank Deutsche Girozentrale now owns 55,482 shares of the real estate investment trust’s stock worth $4,076,000 after acquiring an additional 2,273 shares during the period. 62.51% of the stock is currently owned by institutional investors.

National Health Investors Trading Up 2.1%

Shares of National Health Investors stock opened at $71.30 on Friday. The firm’s 50 day moving average is $71.16 and its 200 day moving average is $71.92. The firm has a market capitalization of $3.33 billion, a PE ratio of 22.63, a price-to-earnings-growth ratio of 3.60 and a beta of 0.73. National Health Investors, Inc. has a 1 year low of $65.13 and a 1 year high of $86.13. The company has a current ratio of 16.55, a quick ratio of 16.55 and a debt-to-equity ratio of 0.88.

National Health Investors (NYSE:NHIGet Free Report) last issued its earnings results on Monday, May 5th. The real estate investment trust reported $1.15 earnings per share for the quarter, beating analysts’ consensus estimates of $1.13 by $0.02. The firm had revenue of $68.87 million for the quarter, compared to analyst estimates of $85.13 million. National Health Investors had a net margin of 41.15% and a return on equity of 10.64%. The company’s quarterly revenue was up 9.6% on a year-over-year basis. During the same quarter last year, the business posted $1.10 earnings per share. Equities research analysts forecast that National Health Investors, Inc. will post 4.41 earnings per share for the current fiscal year.

National Health Investors Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, August 1st. Shareholders of record on Monday, June 30th were issued a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a yield of 5.0%. The ex-dividend date of this dividend was Monday, June 30th. National Health Investors’s dividend payout ratio is presently 114.29%.

Analyst Upgrades and Downgrades

NHI has been the topic of a number of recent analyst reports. Wedbush raised shares of National Health Investors to a “strong-buy” rating in a research note on Wednesday, July 2nd. KeyCorp upgraded National Health Investors from a “sector weight” rating to an “overweight” rating and set a $80.00 price target on the stock in a research note on Thursday, July 10th. Finally, Truist Financial raised National Health Investors from a “hold” rating to a “buy” rating and set a $77.00 price target for the company in a report on Wednesday, July 2nd. Two research analysts have rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $84.60.

View Our Latest Research Report on NHI

National Health Investors Profile

(Free Report)

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

See Also

Institutional Ownership by Quarter for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.